Skip to content
AdAdvertisement
Value Science Weekly — health economics and market access, in your inbox

Category

Healthcare systems

How health systems are financed, organised and reformed, and what that means for the adoption of new technologies. Comparative where it is useful, specific where the detail matters.

291 articles in this topic.

Articles in this category

NHLS Governance Crisis Reaches Parliament With R1.8 Billion in Irregular Spending

11/13/2026

NHLS Governance Crisis Reaches Parliament With R1.8 Billion in Irregular Spending

The NHLS governance crisis reached Parliament with R1.8 billion in irregular spending, an interim board and a disputed IP Capital consultancy.
Read Article →
US MFN Drug Pricing: A 25% German Price Rise Would Cut Medicaid Savings by 3.8%

11/12/2026

US MFN Drug Pricing: A 25% German Price Rise Would Cut Medicaid Savings by 3.8%

A preprint led by Thomas Hwang models how German price changes affect US Medicaid MFN savings and German statutory health insurance spending.
Read Article →
Neuquén Health Technology Assessment Agency: What Law 3563 Sets Up

11/10/2026

Neuquén Health Technology Assessment Agency: What Law 3563 Sets Up

Law 3563 creates a Neuquén health technology assessment agency. Guadalupe Montero explains how it will weigh safety, benefit, equity and budget impact.
Read Article →
Enzutrix Patent Dispute Heads to Constitutional Court: Hearing Set for 23 November

11/10/2026

Enzutrix Patent Dispute Heads to Constitutional Court: Hearing Set for 23 November

The Enzutrix patent dispute goes to South Africa's Constitutional Court on 23 November 2026. UC and Astellas are pursuing damages over the generic prostate cancer drug, while Eurolab argues the patent was never validly obtained. #SyenzaNews #MarketAccess
Read Article →
CMS Finalizes GLOBE Model Drug Pricing for Medicare Part B Drugs

11/9/2026

CMS Finalizes GLOBE Model Drug Pricing for Medicare Part B Drugs

CMS finalizes the GLOBE Model drug pricing rule, benchmarking Medicare Part B drug rebates against international prices from April 2027. #SyenzaNews #MarketAccess
Read Article →
Medicare drug price negotiation: CMS sets permanent rules

11/9/2026

Medicare drug price negotiation: CMS sets permanent rules

The final rule also covers a temporary price floor for small biotech drugs and Part D plan payments to dispensing entities. #SyenzaNews #DrugPricing #MarketAccess
Read Article →
EMA Mid-Year Report 2026: Reform, Supply and the First Joint Clinical Assessment

11/4/2026

EMA Mid-Year Report 2026: Reform, Supply and the First Joint Clinical Assessment

The EMA mid-year report 2026 records 485 scientific advice requests in the first half, the first joint clinical assessment under the HTA Regulation and progress on the new pharmaceutical law. #SyenzaNews #MarketAccess
Read Article →
Generic lenacapavir HIV prevention gets FDA tentative approval

11/3/2026

Generic lenacapavir HIV prevention gets FDA tentative approval

Dr. Reddy's has FDA tentative approval for generic lenacapavir HIV prevention, priced at US$40 per person per year across 120 countries. #SyenzaNews #HIVprevention #MarketAccess
Read Article →
PBS Strategic Agreements: What Government and Industry Told Patients Before the Next Deal

11/2/2026

PBS Strategic Agreements: What Government and Industry Told Patients Before the Next Deal

Australia's PBS strategic agreements with the medicines industry expire on 30 June 2027. At a 23 October webinar, the health department, GBMA and Medicines Australia explained what the deals cover, how patients can feed in, and where industry says they have fallen short on access. #SyenzaNews #MarketAccess #HTA #PBS #Australia
Read Article →
Labor Department Finalizes PBM Fee Disclosure Rule for Large Self-Insured Plans

10/30/2026

Labor Department Finalizes PBM Fee Disclosure Rule for Large Self-Insured Plans

The US Department of Labor has finalized its PBM fee disclosure rule. From plan years beginning on or after 1 July 2027, PBMs must disclose rebates, spread compensation, copay claw-backs and per-drug net prices to large self-insured ERISA plans, report twice a year, and accept an annual audit by an auditor the plan chooses. EBSA estimates $818.4 million a year in transfers from PBMs to plans and participants. #SyenzaNews #PBM #DrugPricing #MarketAccess
Read Article →
Lancet Authors Make the Case for an EU Medical Device Agency

10/30/2026

Lancet Authors Make the Case for an EU Medical Device Agency

Four authors writing in The Lancet Regional Health - Europe say the Commission's MDR and IVDR simplification proposal keeps the core flaw: notified bodies still decide, one by one, whether innovative devices reach the market. They argue for an EU medical device agency with binding powers over strategy, guidance and advice. #SyenzaNews #MedTech #MedicalDevices #MarketAccess
Read Article →
Portugal Outpatient Medicine Spend Rises 7.9%, Led by Diabetes Drugs

10/29/2026

Portugal Outpatient Medicine Spend Rises 7.9%, Led by Diabetes Drugs

Portugal's outpatient medicine bill rose 7.9% in January to August 2026. Antidiabetics drove nearly a third of the increase, and semaglutide spend rose 54.5%. #SyenzaNews #MarketAccess #HealthEconomics
Read Article →

Related topics